Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milciclib maleate in unresectable or metastatic hepatocellular carcinoma
MOH_2017-05-04_000354Phase 2Not yet recruiting
- Sponsor
- Tiziana Life Sciences
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of milciclib in hepatocellular carcinoma (HCC), sponsored by Tiziana Life Sciences. Planned start Apr 2017; status: not yet recruiting.
02
Drugs
milciclib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on MOH_2017-05-04_000354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-05-04_000354.